Margaret Krackeler, MD, of Kaiser Permanente Northern California, shares lessons on implementing evidence-based formulary changes for patients with CLL.
Explore the evolving approach to cancer treatment, emphasizing personalized care and active surveillance over aggressive interventions for low-risk cases.
Several potentially practice-changing phase 3 trials alongside promising results in emerging strategies in chronic lymphocytic leukemia (CLL) presented at the 2025 American Society of Hematology ...
Those seeking assistance under the Radiation Exposure Compensation Act now have more options when applying in Southern Utah.
In this article, we will look at the 12 Best Healthcare Stocks Under $50 to Invest In. On January 27, Jared Holz, healthcare ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results